Cargando…
Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
Autores principales: | Newman, C. E., Cox, R., Ford, C. H., Johnson, J. R., Jones, D. R., Wheaton, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977056/ https://www.ncbi.nlm.nih.gov/pubmed/3888243 |
Ejemplares similares
-
Razoxane-induced polyploidy.
por: Taylor, I. W., et al.
Publicado: (1978) -
Reduction of daunomycin toxicity by razoxane.
por: Wang, G., et al.
Publicado: (1981) -
The mutagenic activity of razoxane (ICRF 159): an anticancer agent.
por: Albanese, R., et al.
Publicado: (1985) -
Combination therapy of a mouse sarcoma using razoxane and electron irradiation.
por: Grimshaw, M. B., et al.
Publicado: (1981) -
Carbon-ion radiotherapy for inoperable endometrial carcinoma
por: Irie, Daisuke, et al.
Publicado: (2018)